Corporate Profile
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, WA, Cambridge, MA, and South San Francisco, CA.
Minimum 15 minutes delayed. Source: LSEG
News Releases
Apr 27, 2026
Apr 13, 2026
Mar 13, 2026
Events
Mar 11, 2026 at 1:40 PM EDT
Mar 2, 2026 at 1:10 PM EST
SEC Filings
| Filing date | Description | Form |
|---|---|---|
| Report of unscheduled material events or corporate event | 8-K | |
| Official notification to shareholders of matters to be brought to a vote ("Proxy") | DEF 14A | |
| Additional proxy soliciting materials - definitive | DEFA14A |